Cibus

The healthcare sector remains one of the most active areas for speculative growth investors, particularly as clinical-stage biotechnology firms continue reporting progress across key development programs. Companies focused on unmet medical needs, novel therapeutic approaches, and advancing regulatory pathways are now attracting increased scrutiny as markets look ahead to potential data readouts and commercialization opportunities. … Read more